You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
24 April 2024
Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales
17 April 2024
Annual General Meeting of Kuros Biosciences approves all resolutions
13 March 2024
Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023
8 March 2024
Kuros Biosciences to Report Full Year Financial Results for 2023 and Provide Corporate Update
1 February 2024
Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference
31 January 2024
Kuros Biosciences Receives US FDA 510K Clearance for MagnetOs Granules for Interbody Use and Regulatory Clearance of MagnetOs Granules and MagnetOs Putty in New Zealand